Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Summary

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of intramuscular INGAP Peptide given for the first time in humans as a potential treatment for diabetes.

Timeline

Start

2001-12

Primary completion

—

Completion

—

Drugs

Indications